Cargando…

Are there employment and income gains of a national breast cancer screening program?

BACKGROUND: The Dutch national breast cancer screening program invites women aged 50–75 for screening. By detecting the disease in an early phase, the program aims to achieve lower breast cancer mortality and improve breast cancer survivors’ health. Arguably, the latter also improves the employabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Kambourova, Zornitza, Kalwij, Adriaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210695/
https://www.ncbi.nlm.nih.gov/pubmed/35727354
http://dx.doi.org/10.1186/s13561-022-00380-0
_version_ 1784730210247114752
author Kambourova, Zornitza
Kalwij, Adriaan
author_facet Kambourova, Zornitza
Kalwij, Adriaan
author_sort Kambourova, Zornitza
collection PubMed
description BACKGROUND: The Dutch national breast cancer screening program invites women aged 50–75 for screening. By detecting the disease in an early phase, the program aims to achieve lower breast cancer mortality and improve breast cancer survivors’ health. Arguably, the latter also improves the employability of diagnosed women. OBJECTIVE: This study investigates the effects of the Dutch national breast cancer screening program on diagnosed women’s employment and income. METHODS: The empirical analysis uses data of 229,357 women aged 40–59, of whom 10,515 were diagnosed with breast cancer at an age in the range 47–53. A regression-based difference-in-differences estimator is used to identify program effects by comparing outcomes for women diagnosed at ages 47–49 with the outcomes for those diagnosed at ages 50–53. The empirical models account for individual fixed effects, and for age and year fixed effects by using a control group of women who were not diagnosed with breast cancer. RESULTS: Women’s employment rates declined in the six-year period after a breast cancer diagnosis with, on average, about 3 percentage points and their incomes declined with, on average, about 5% over this period. The empirical evidence, based on a comparison of outcomes for women diagnosed at ages 47–49 with the outcomes for those diagnosed at ages 50–53 when covered by the breast cancer screening program, does not support that these declines in employment and income were affected by the program. The evidence also does not support short or medium-term survival gains of the program. CONCLUSIONS: The findings of this study suggest that the Dutch national breast cancer screening program yields no discernible short or medium-term employment and income gains for women diagnosed with breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13561-022-00380-0.
format Online
Article
Text
id pubmed-9210695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92106952022-06-22 Are there employment and income gains of a national breast cancer screening program? Kambourova, Zornitza Kalwij, Adriaan Health Econ Rev Research BACKGROUND: The Dutch national breast cancer screening program invites women aged 50–75 for screening. By detecting the disease in an early phase, the program aims to achieve lower breast cancer mortality and improve breast cancer survivors’ health. Arguably, the latter also improves the employability of diagnosed women. OBJECTIVE: This study investigates the effects of the Dutch national breast cancer screening program on diagnosed women’s employment and income. METHODS: The empirical analysis uses data of 229,357 women aged 40–59, of whom 10,515 were diagnosed with breast cancer at an age in the range 47–53. A regression-based difference-in-differences estimator is used to identify program effects by comparing outcomes for women diagnosed at ages 47–49 with the outcomes for those diagnosed at ages 50–53. The empirical models account for individual fixed effects, and for age and year fixed effects by using a control group of women who were not diagnosed with breast cancer. RESULTS: Women’s employment rates declined in the six-year period after a breast cancer diagnosis with, on average, about 3 percentage points and their incomes declined with, on average, about 5% over this period. The empirical evidence, based on a comparison of outcomes for women diagnosed at ages 47–49 with the outcomes for those diagnosed at ages 50–53 when covered by the breast cancer screening program, does not support that these declines in employment and income were affected by the program. The evidence also does not support short or medium-term survival gains of the program. CONCLUSIONS: The findings of this study suggest that the Dutch national breast cancer screening program yields no discernible short or medium-term employment and income gains for women diagnosed with breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13561-022-00380-0. Springer Berlin Heidelberg 2022-06-21 /pmc/articles/PMC9210695/ /pubmed/35727354 http://dx.doi.org/10.1186/s13561-022-00380-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kambourova, Zornitza
Kalwij, Adriaan
Are there employment and income gains of a national breast cancer screening program?
title Are there employment and income gains of a national breast cancer screening program?
title_full Are there employment and income gains of a national breast cancer screening program?
title_fullStr Are there employment and income gains of a national breast cancer screening program?
title_full_unstemmed Are there employment and income gains of a national breast cancer screening program?
title_short Are there employment and income gains of a national breast cancer screening program?
title_sort are there employment and income gains of a national breast cancer screening program?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210695/
https://www.ncbi.nlm.nih.gov/pubmed/35727354
http://dx.doi.org/10.1186/s13561-022-00380-0
work_keys_str_mv AT kambourovazornitza arethereemploymentandincomegainsofanationalbreastcancerscreeningprogram
AT kalwijadriaan arethereemploymentandincomegainsofanationalbreastcancerscreeningprogram